ONCOTYPE DX FOR NODE POSITIVE BREAST CANCER

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2014-09-22 for ONCOTYPE DX FOR NODE POSITIVE BREAST CANCER manufactured by Genomic Health.

Event Text Entries

[4925390] Oncologist (b)(6) used the oncotype dx test to deny chemotherapy for stage iib bilateral breast cancer, event though it was not a validated test for node positive breast cancer in early 2012. It appears there is no prohibition on such use nor is there any warning to patients that it is investigation. The test showed a recurrence score of 20 and no benefit from chemotherapy. All traditional measures of the need for chemotherapy indicated, i should have received chemotherapy and the nccn guidelines recommended chemotherapy. I developed metastases 15 months after surgery. At that point, i learned from a review of my medical records that (b)(6) used this test to deny me chemotherapy (which i had requested). There appears to be no standards governing the use of this test, no warnings to patients that it is investigational and no way a patient can dispute its use in making treatment decisions.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW5038354
MDR Report Key4121910
Date Received2014-09-22
Date of Report2014-09-22
Date Added to Maude2014-09-29
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Reporter OccupationPATIENT
Health Professional0
Initial Report to FDA3
Report to FDA0
Event Location0
Single Use0
Previous Use Code0
Event Type3
Type of Report3

Device Details

Brand NameONCOTYPE DX FOR NODE POSITIVE BREAST CANCER
Generic NameONCOTYPE DX FOR NODE POSITIVE BREAST CANCER
Product CodeNSU
Date Received2014-09-22
Device Sequence No1
Device Event Key0
ManufacturerGENOMIC HEALTH


Patients

Patient NumberTreatmentOutcomeDate
101. Life Threatening 2014-09-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.